Research Article
High Expression of SMO and GLI1 Genes with Poor Prognosis in Malignant Mesothelioma
Table 9
Univariate analysis of prognostic risk factors for malignant mesothelioma.
| Clinical features | (%) | 95% CI (SMO) | (SMO) | 95% CI (GLI1) | (GLI1) |
| Sex | Male | 60 | 2.723 (1.149-6.454) | 0.023 | 3.080 (1.311-7.235) | 0.01 | Female | 70 | Age (years) | <60 | 39 | 0.653 (0.274-1.554) | 0.335 | 0.650 (0.272-1.552) | 0.332 | ≥60 | 91 | Asbestos exposure history | Yes | 85 | 0.331 (0.128-0.857) | 0.023 | 0.269 (0.099-0.732) | 0.010 | No | 45 | Pathological changes | Pleural | 60 | 0.521 (0.204-1.328) | 0.172 | 0.730 (0.325-1.643) | 0.447 | Peritoneal | 70 | P53 | Negative | 51 | 0.506 (0.222-1.151) | 0.104 | 0.619 (0.277-1.386) | 0.244 | Positive | 79 |
|
|